focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Announces Cobra Cure (TM)FX UV LED

9 Sep 2015 07:00

RNS Number : 4677Y
ProPhotonix Limited
09 September 2015
 

 

September 9, 2015

 

ProPhotonix Limited

("ProPhotonix" or "the Company")

ProPhotonix introduces COBRA Cure™ FX UV LED Lamp with IntelliSenseTM Smart Sensing Technology

Stackable Design, Field-Replaceable Window, Multiple Optical Output Options, Innovative sensing software

 

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, today announces the launch of the COBRA Cure FX, a UV LED lamp ideally suited to a range of ultra violet ("UV") curing applications. COBRA Cure FX is a patent pending, compact, fan-cooled UV LED lamp in a stackable form factor that produces a uniform line with a peak irradiance of 4 W/cm2 and peak energy density (dose) of 3 J/cm2. COBRA Cure FX is offered in numerous optical configurations and is available in a range of wavelengths including 365nm, 385nm 395nm and 405nm. Multiple wavelength versions are also available.

LED illumination offers significant benefits versus traditional UV lamps including longer illuminator lifetimes, high stability light output, precise control, thermal management, ozone-free, heavy metal free, and lower total cost of ownership.

 

The COBRA Cure FX unique design includes a field-replaceable exit window. In certain operating environments, materials can build-up over time on the outer surface of the window which reduces the intensity of the light causing a degradation of system performance. Without this unique design, the operator must manually clean the emitter window which causes machine down time but also causes abrasion damage to the window thus reducing the light's effectiveness during operation. The field-replaceable window allows fast and efficient changes by non-technical personnel. This innovative patent pending design is easy to use, requires no special tools for window replacement, and ensures that the window is secure during operation, thus minimizing system downtime.

COBRA Cure FX also incorporates IntelliSense, a patent pending new smart sensing technology which provides precise output control, operational intelligence and "Plug & Play" integration for end users. Sensing features include: real-time thermal monitoring, a necessity ensuring proper system operation; intensity monitoring, providing operating irradiance and efficiency data; lifetime prediction of the lamp, reliability and longevity estimates; and numerous health & safety features. IntelliSense is the state of the art sensing capability in illumination.

Commenting on the COBRA Cure FX launch, Tim Losik, CEO and President of ProPhotonix, said:

"Over the past two years we have assessed various markets and product features and have developed a product strategy focusing on large markets complemented by our design capabilities. To this end, we are concentrating our engineering talents in a couple of specific market areas which we believe are poised for fast market expansion. One of these is the ultra violet LED and laser market, addressing various applications including: printing, curing, 3D printing, bio-luminescence, medical microscopy, and other applications. Market research shows that the 2014 market size for UV LED applications was approximately $90 million with projected growth to $500 million by 2019, a compound average annual growth rate of nearly 40%.

"This product redefines the capabilities of the world's best UV LED lamps by increasing the operational capabilities and improving customer ease of use. As this product line develops, we intend to introduce more exciting enhancements and capabilities for users. To protect our intellectual property rights within this product, United States Patent Applications have recently been filed covering several of the unique features of the product design including the capabilities of IntelliSense. We will continue to file patent applications, where appropriate, to protect our expanding intellectual property portfolio."

 

For more information about ProPhotonix' COBRA Cure FX, visit http://www.prophotonix.com/products/UV-Solutions/

 

Enquiries:

ProPhotonix Limited

Tim Losik

 

sales@prophotonix.com

 

Tel: +1 603 893 8778

 

N+1 Singer

Ben Wright/ Richard Salmond

Tel: +44 (0) 207 496 3000

Nominated Adviser and Broker

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly Opnext), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, ultra violet applications, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

Cautionary Statement 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

 

 

 

 

 

 

 

 

 

#######

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADVLFBEKFEBBD
Date   Source Headline
1st Sep 20175:00 pmRNSTR-1 Holding(s) in Company 2017 (4)
1st Sep 20172:34 pmRNSTR-1 Holding(s) in Company 2017 (3)
31st Aug 20176:00 pmRNSTRI-1 Holding(s) in Company 2017 (2)
31st Aug 20173:04 pmRNSTR-1 Holding(s) in Company 2017
31st Aug 20177:00 amRNSProPhotonix Announces Date For First Half Results
21st Aug 20177:00 amRNSUpdate Regarding New Restricted Line Stock
17th Aug 20177:00 amRNSProPhotonix Announces New Restricted Line Stock
17th Jul 20177:00 amRNSProPhotonix delivers 190,000 LED and Laser Modules
14th Jul 20177:00 amRNSTrading update and extension of Rights Plan
29th Jun 20177:00 amRNSProPhotonix Celebrates 15 Years Industry Support
13th Jun 20177:00 amRNSProPhotonix Delivers Laser Modules for 3D Printing
6th Jun 20177:00 amRNSGrant of Options
30th May 20177:00 amRNSProPhotonix Laser Module for Robotic Guidance
19th May 20177:00 amRNSProPhotonix AGM Results May 2017
18th May 20177:00 amRNSAGM Statement 18 May 2017
10th Apr 20177:00 amRNSDirector/PDMR Dealings and Issue of Equity
6th Apr 20177:00 amRNSProphotonix Announces Posting Notice of AGM
3rd Apr 20177:00 amRNSProPhotonix honored by Vision Systems Design 2017
31st Mar 20177:00 amRNSPROPHOTONIX ANNOUNCES CHANGE OF REGISTERED ADDRESS
23rd Mar 20177:00 amRNSNotice of Annual Financial Report
14th Mar 20177:00 amRNSNotice of AGM Preliminary Results Year End 2016
19th Jan 20177:00 amRNSProPhotonix Cobra Multispec Product Announcement
10th Jan 20177:00 amRNSDirector/PDMR Shareholding
19th Dec 20167:00 amRNSProPhotonix Announces Trading Update
6th Dec 20167:00 amRNSProPhotonix Expands European Sales Team
15th Nov 20167:00 amRNSProPhotonix Extends COBRA LED Line Light Series
8th Sep 20167:00 amRNSINTERIM RESULTS FOR HALF YEAR ENDED JUNE 30, 2016
6th Sep 20167:00 amRNSProPhotonix Introduces the Cobra Cure FX3
1st Sep 20167:00 amRNSProPhotonix to Exhibit UV LED Curing System
15th Jun 20167:00 amRNSProPhotonix Receives $1.1 million Order
20th May 20167:00 amRNSAGM Results and Director Dealings 2016
19th May 20167:00 amRNSAGM Statement-May 19, 2016
5th May 20167:00 amRNSDirector Dealing
13th Apr 20167:00 amRNSDirector Dealing
7th Apr 20167:00 amRNSPOSTING OF NOTICE OF ANNUAL GENERAL MEETING
23rd Mar 20167:00 amRNSPosting of Annual Report and Accounts
17th Mar 20167:00 amRNSProPhotonix extends COBRA CURE FX Series
15th Mar 20167:00 amRNSAnnual Financial Report
2nd Feb 20167:00 amRNSProPhotonix adds new Green Laser Diode
14th Jan 20167:00 amRNSProPhotonix adds new 10mW Green Laser Diode
6th Jan 201611:14 amRNSChange of Adviser Name
22nd Dec 20157:00 amRNSChange of Nominated Adviser and Broker
9th Sep 20157:00 amRNSProPhotonix Announces Cobra Cure (TM)FX UV LED
9th Sep 20157:00 amRNSProPhotonix Announces Interim Results
1st Sep 20157:04 amRNSHolding(s) in Company
24th Aug 20157:00 amRNSThree Year Supply Agreement
22nd Jun 20157:00 amRNSProPhotonix Exhibits New Fiber Coupled Laser
9th Jun 20157:00 amRNSProPhotonix adds new Laser Diode from Ushio
4th Jun 20157:43 pmEQSDGAP-Regulatory: ProPhotonix Limited:
29th May 20157:00 amRNSRe Share Trading Lines

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.